Biomarkers of Inflammation and Neuronal and Glial Injury and their Correlation with Disease Severity and Progression in Leucine-Rich Glioma Inactivated-1 (LGI1) Autoimmune Encephalitis (P1-8.006)
To correlate clinical outcomes measures including Modified Rankin Score (mRS) and Montreal Cognitive Assessment (MOCA) with blood-based biomarkers in anti-Leucine-Rich Glioma Inactivated-1 (LGI1) Autoimmune Encephalitis (AE) as possible biomarkers of disease severity and long-term outcomes.
Authors
- Stefan Sillau (ORCID: https://orcid.org/0000-0002-8691-3139)
- Kelli M. Money (ORCID: https://orcid.org/0000-0002-7432-5882)
- Jeffrey L. Bennett (ORCID: https://orcid.org/0000-0002-3346-1394)
- Sean Selva
- Gregory P. Owens (ORCID: https://orcid.org/0000-0003-2510-2997)
- Amanda L. Piquet (ORCID: https://orcid.org/0000-0001-7349-6455)
- Paul D. Crane (ORCID: https://orcid.org/0000-0001-7875-5831)
- Tyler Borko
- Sadie Eggmann
- Alanna Ritchie (ORCID: https://orcid.org/0009-0007-6970-7687)
- Phillip Winters
Institutions
- University of Colorado System (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211693
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00